BioLineRx Reports Second Quarter 2021 Financial Results and Provides Corporate Update
Go back to BioLineRx Reports Second Quarter 2021 Financial Results and Provides Corporate Update| BIOLINE RX SP ADR (NASDAQ: BLRX) | Delayed: 2.53 +0.05 (2.02%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.48 | 52 Week High | $1.63 | |||
| Open | $2.63 | 52 Week Low | $0.71 | |||
| Day High | $2.63 | P/E | N/A | |||
| Day Low | $2.43 | EPS | $0.00 | |||
| Volume | 11,865 | |||||
| BIOLINE RX SP ADR (NASDAQ: BLRX) | Delayed: 2.53 +0.05 (2.02%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.48 | 52 Week High | $1.63 | |||
| Open | $2.63 | 52 Week Low | $0.71 | |||
| Day High | $2.63 | P/E | N/A | |||
| Day Low | $2.43 | EPS | $0.00 | |||
| Volume | 11,865 | |||||

